Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2025-06-25Clinical Trial Update: Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1
A clinical trial update notes cases of interstitial pneumonitis associated with combining EGFR tyrosine kinase inhibitors (EGFR-TKIs) and PD…
-
CLINICAL_TRIALS safety_alert · 2025-03-25Clinical Trial Update: Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases
A completed clinical trial update evaluating pulmonary physiology and systemic inflammatory responses associated with brigatinib use in non-…
-
CLINICAL_TRIALS safety_alert · 2025-03-14Clinical Trial Update: LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
The document reports lorlatinib-associated hyperlipidemia in ALK-positive non-small cell lung cancer and notes monitoring considerations in …
-
CLINICAL_TRIALS safety_alert · 2019-02-19Clinical Trial Update: Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer
This clinical trial update discusses the side effects observed with anti-PD-1/PD-L1 and anti-CTLA-4 therapies in non-small cell lung cancer.